Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Influence of the Mismatched Minor Antigen HA-3 on Clear Graft Survival in Humans

Böhringer D.1, Reinhard T.2, Enczmann J.3, Spierings E.4, Goulmy E.4, Wernet P.3, Sundmacher R.1
1Eye hospital, 3Bone Marrow Donor centre and Institute for Transplantation Immunology, Heinrich-Heine-University, Düsseldorf; 2Eye Hospital, Albert-Ludwigs-University, Freiburg; 4Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden/NL

Purpose: Minor antigens (H) are HLA-restricted peptide-fragments of allelic cytosolic proteins. In animal-model keratoplasty, mismatched H-alleles presented within compatible HLA-molecules of the graft even exceed immunogenicity of mismatched HLA-molecules. Thus, in high-risk keratoplasty, where good HLA-compatibility is generally aimed at, additional matching of relevant H-loci is supposed to be beneficial. Immunogenic H-loci in human keratoplasty are currently undefined. HA-3 is an H-antigen that is presented within HLA-A1 and known to be expressed in human corneas. It can come as one of two alleles (T+/-): T+ is immunogenic to T-.
Method: HA-3 typing was performed retrospectively for 77 HLA-A1-compatible penetrating keratoplasties from deposited corneoscleral rims and peripheral blood cells, respectively. In both the immunogenic group (T+ graft for T- recipient) (n=8) and non-immunogenic controls (n=69) rejection-free clear graft survival was estimated


Zurück | Back